In a matter of days, global dealmakers have signaled that 2025 is shaping up to be one of the most consequential years for mergers and acquisitions since the pre-pandemic boom. A cluster of high-value transactions — spanning semiconductors, life sciences, payments infrastructure, and food delivery — has placed cross-border deals firmly back at the top of the boardroom agenda. For CFOs, General Counsel, and M&A Directors navigating this environment, the pace and scale of activity demand both strategic clarity and rigorous execution discipline.

A Wave of Large-Cap Transactions Reshapes Key Sectors

The headline figures are striking. GameStop has confirmed it will pursue an unsolicited cash-and-stock offer of approximately $56 billion to acquire eBay, despite the e-commerce platform’s formal rejection — a move that escalates pressure on eBay’s board and raises immediate questions under U.S. securities law and EU foreign investment screening frameworks. Simultaneously, Stripe and Advent International have jointly tabled a $53 billion offer for PayPal Holdings, one of the most significant convergences of private equity and strategic capital in the payments sector in recent memory.

In the technology hardware space, ON Semiconductor’s all-stock $7 billion acquisition of Synaptics reflects the accelerating consolidation narrative around AI-enabled devices. This transaction is emblematic of a broader trend: semiconductor and component manufacturers are using corporate finance vehicles to rapidly build AI-adjacent portfolios rather than relying solely on organic R&D cycles. Meanwhile, Uber’s $14.8 billion public takeover offer for Delivery Hero — a Frankfurt-listed company — introduces meaningful cross-jurisdictional complexity, triggering review obligations under both the EU Merger Regulation (EUMR) and potentially Germany’s Foreign Trade and Payments Act (AWG).

Life Sciences and Deep Tech: Europe at the Centre of Deal Flow

Merck KGaA’s agreement to acquire U.S.-based Bio-Techne for $11.3 billion — its largest transaction in over a decade — underscores the continued appetite among European strategic acquirers for transatlantic life sciences assets. This deal reflects a structural shift: European corporates with strong balance sheets are increasingly willing to deploy capital into U.S. targets to access proprietary biotech platforms, regulatory approvals, and distribution infrastructure.

From a European perspective, this deal will attract scrutiny under both U.S. Committee on Foreign Investment (CFIUS) protocols and the EU’s evolving Foreign Subsidies Regulation (FSR), which came into full effect in October 2023. Boards and General Counsel advising on similar transactions should factor in extended regulatory timelines — potentially 12 to 18 months — and build contingency provisions accordingly into deal structuring and due diligence frameworks.

Implications for Decision-Makers: Execution Risk Is the New Premium

The volume and velocity of current deal activity creates a paradox: while market conditions favour bold strategic moves, the execution risk associated with large-scale post-merger integration has never been higher. Several factors demand attention from senior leadership teams:

  • Regulatory fragmentation: Cross-border deals now routinely trigger parallel review processes across multiple jurisdictions. The Uber–Delivery Hero transaction alone may require filings in the EU, Germany, and several Asian markets where Delivery Hero operates.
  • Valuation discipline: With interest rates remaining elevated across the eurozone and the U.S., all-stock structures (as seen in the ON Semiconductor–Synaptics deal) are regaining favour — but require careful dilution analysis and shareholder alignment strategies.
  • Integration planning at signing, not closing: Organisations that treat post-merger integration as a post-closing exercise consistently underperform. Leading acquirers are embedding integration workstreams into the due diligence phase itself, particularly for technology and IP-heavy targets.
  • Private equity dynamics: The Stripe–Advent joint bid for PayPal illustrates how venture capital and private equity sponsors are increasingly co-investing on mega-cap targets — a structural shift that changes negotiation dynamics, governance expectations, and exit horizon planning.

For boards evaluating inbound or outbound M&A opportunities, the current environment rewards preparation over opportunism. Scenario modelling, pre-emptive regulatory mapping, and robust integration governance are no longer optional — they are the baseline for credible deal execution.

Key Takeaway

The $140+ billion in announced or pursued transactions over a single week reflects a structural, not cyclical, shift in global M&A activity. Consolidation is accelerating across AI hardware, payments, life sciences, and consumer platforms — driven by a combination of strategic urgency, available capital, and competitive pressure. For European and transatlantic dealmakers, the opportunity is real, but so is the complexity. Firms that invest in rigorous due diligence, early regulatory engagement, and disciplined post-merger integration planning will define the next generation of market leaders.